The PMPRB has outlived its usefulness: Nigel Rawson in the Hill Times
This article originally appeared in the Hill Times. By Nigel Rawson, June 28, 2023 The Patented Medicine Prices Review Board (PMPRB), ...
Tag: PMPRB
Let’s hope turmoil at drug price review board portends end of outdated agency: Richard Owens in the National Post
This article originally appeared in the National Post. By Richard Owens, May 23, 2023 The federal agency that controls wholesale ...
The drug prices review board was once a solution. It’s now a problem: Nigel Rawson and John Adams in the Financial Post
This article originally appeared in the Financial Post. By Nigel Rawson and John Adams, March 1, 2023 Journalist Kelly Crowe and others repeat ...
PMPRB continues plan to drive down drug prices as patients suffer: Nigel Rawson and John Adams for Inside Policy
By Nigel Rawson and John Adams, November 23, 2022 For seven years, the Patented Medicines Prices Review Board (PMPRB) – ...
The Patented Medicine Prices Review Board has lost its way (again)
By W. Neil Palmer November 1, 2022 PDF of commentary The Patented Medicine Prices Review Board (PMPRB) is once again ...
Why Canada Should Pay More for Medications: Richard C. Owens in the Wall Street Journal
This article originally appeared in the Wall Street Journal. Below is an excerpt from the article, which can be read ...
Exposing 12 myths that support drug price controls and harm our health system
OTTAWA, ON (June 28, 2022): Is the Patented Medicine Prices Review Board (PMPRB) causing more harm than good? A recent ...
Reality check: Dispelling the myths around the benefits of drug price controls
By Richard C. Owens with Rebecca Rosenberg and Haya Sardar June 28, 2022 PDF of paper Executive Summary Canada’s Patented ...
MLI paper finds Canada’s drug price controls hurt both innovation and Canadians’ access to medication
OTTAWA, ON (June 2, 2022): The PMPRB, a regulatory body formed in 1987, was never a principled policy initiative targeted ...
The kindest cut: Excising the Patented Medicine Prices Review Board from the Canadian body politic
By Richard C. Owens, Rebecca Rosenberg, and Haya Sardar June 2, 2022 PDF of paper Executive Summary Canada’s drug price ...
Ottawa should reset its relationship with drug developers to improve patient health: Rawson and Adams for Inside Policy
By Nigel Rawson and John Adams, May 2, 2022 On April 14, 2022, Health Minister Jean-Yves Duclos announced the federal ...
Canadians will pay a heavy price as Ottawa cuts drug costs
A new MLI commentary warns that pending and aggressive drug price control efforts could lead to major unintended consequences in ...
-
Time for an intervention – an urgent call to end “gender-affirming” treatments for children: J. Edward Les for Inside Policy
-
The Governor General deserves better, but we deserve impartiality: Philippe Lagassé for Inside Policy
-
The Lamentable Decline of Canada’s Reputation as a Dependable and Globally Respected Nation: Peter Menzies in the Epoch Times
-
Conservatives can reject destructive left-wing policies and still take climate change seriously: Brian Lee Crowley in the National Post
-
Success assured? Appraising the Canadian-led Enhanced Forward Presence battlegroup in Latvia
